Keyphrases
Non-associated
100%
Functional Variants
100%
Treatment Response
100%
Cytochrome P450 3A4 (CYP3A4)
100%
Cluster Headache
100%
Polygenetic Risk
100%
Verapamil
40%
Triptans
20%
Headache Treatment
20%
Cluster Treatment
10%
Line Cluster
10%
Structured Interview
10%
Metabolic Pathway
10%
Candidate Gene Approach
10%
Variation in Treatment
10%
Headache Response
10%
Polygenic Risk Score
10%
Clinically Significant
10%
Meta-analysis
10%
Genetic Factors
10%
Genetic Variants
10%
Migraine
10%
High Genetic Risk
10%
Single nucleotide Polymorphism
10%
Inter-individual Variation
10%
International Classification of Headache Disorders
10%
Genome-wide Association Study
10%
Neuroscience
Cluster Headache
100%
Cytochrome P450 3A4
100%
Verapamil
40%
Migraine
10%
Genome-Wide Association Study
10%
Single-Nucleotide Polymorphism
10%
Metabolic Pathway
10%
Meta-Analysis
10%
Headache
10%
Pharmacology, Toxicology and Pharmaceutical Science
CYP3A4
100%
Cluster Headache
100%
Verapamil
40%
Triptan Derivative
20%
Chronicity
10%
Migraine
10%
Genetic Risk
10%
Headache and Facial Pain
10%
